Education
About Us
Working with TipRanks
Follow Us
SOPHiA GENETICS (SOPH)
NASDAQ:SOPH
Earnings Data
Report Date
Mar 10, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.22Last Year’s EPS
-0.23Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a strong performance for SOPHiA GENETICS with significant revenue growth, new customer acquisition, and global partnerships. Despite some challenges such as operating losses, cash burn, and regional softness, the company's innovation and strategic expansions provide a positive outlook.Company Guidance
Accelerated Revenue Growth
Revenue grew 23% year-over-year in Q3, and the company raised its 2025 revenue guidance to $75 million to $77 million.
Strong Customer Acquisition
31 new customers were signed in Q3, bringing the total for 2025 to 94, surpassing the 92 customers signed in all of 2024.
U.S. Market Expansion
U.S. revenue grew 30% year-over-year, with notable new customers including Geisinger Health System and Baylor Scott & White Health.
Global Reach and Partnerships
New partnerships in Japan and the U.S. for liquid biopsy applications, with a significant collaboration with AstraZeneca for global deployment.
Innovation and AI Development
Introduction of SOPHiA DDM Digital Twins, an AI-powered research tool for oncologists, and ongoing expansion of AI capabilities.
Healthy Financial Metrics
Gross margin held strong at 73.1%, and adjusted EBITDA improved by 13% year-over-year after excluding Swiss social charges.
SOPH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SOPH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | $5.00 | $4.68 | -6.40% |
Aug 05, 2025 | $3.30 | $3.42 | +3.64% |
May 06, 2025 | $3.14 | $3.00 | -4.46% |
Mar 04, 2025 | $3.57 | $3.10 | -13.17% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does SOPHiA GENETICS (SOPH) report earnings?
SOPHiA GENETICS (SOPH) is schdueled to report earning on Mar 10, 2026, Before Open (Confirmed).
What is SOPHiA GENETICS (SOPH) earnings time?
SOPHiA GENETICS (SOPH) earnings time is at Mar 10, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SOPH EPS forecast?
SOPH EPS forecast for the fiscal quarter 2025 (Q4) is -0.22.